Comparison of Darifenacin and Oxybutynin in Patients with Overactive Bladder: Assessment of Ambulatory Urodynamics and Impact on Salivary Flow

Ambulatory urodynamics appears to be an innovative and potentially useful investigative tool in the evaluation of the efficacy of new therapeutic agents. Darifenacin CR is an efficacious therapy for OAB with comparable effects on urodynamic parameters but producing significantly less dry mouth than oxybutynin.